Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr657 Inhibitors

Olr657 inhibitors represent a unique and specialized class of chemical compounds that primarily interact with the Olr657 receptor, a member of the olfactory receptor family. These receptors are a subgroup within the larger G protein-coupled receptor (GPCR) family, known for their role in the detection of odor molecules. Olr657, specifically, is involved in the binding and response to particular odorants, playing a crucial part in the complex signaling pathways that facilitate the sense of smell. Inhibitors of Olr657 are designed to interfere with the receptor's normal function, providing a means to study the intricate mechanisms of olfactory signaling. These inhibitors can bind to the receptor, preventing the activation by its natural ligands, thereby allowing researchers to dissect the receptor's role in various olfactory processes and its contribution to the broader olfactory system.

The development and study of Olr657 inhibitors also provide valuable insights into the structural and functional aspects of GPCRs. By analyzing how these inhibitors interact with Olr657, scientists can infer details about the receptor's binding sites, conformational changes upon ligand binding, and subsequent intracellular signaling cascades. This knowledge extends beyond olfaction, contributing to a deeper understanding of GPCR functionality in general. Furthermore, the specificity and potency of Olr657 inhibitors are of particular interest, as they highlight the nuanced interplay between receptor structure and ligand design. Advanced techniques in molecular modeling, computational chemistry, and structural biology are often employed to refine these inhibitors, enhancing their selectivity and efficacy. Thus, Olr657 inhibitors are not only pivotal in olfactory research but also serve as a model for studying GPCR interactions and inhibition strategies in a broader scientific context.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Non-selective beta-adrenergic antagonist, might modulate GPCR activity affecting Olr657.

Yohimbine hydrochloride

65-19-0sc-204412
sc-204412A
sc-204412B
1 g
5 g
25 g
$51.00
$171.00
$530.00
2
(1)

Alpha-2 adrenergic receptor antagonist, could affect GPCR signaling pathways related to Olr657.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$124.00
$240.00
$530.00
$999.00
$1530.00
2
(1)

Beta-adrenergic antagonist with alpha-1 blocking activity, potentially influencing Olr657 signaling.

Labetalol

36894-69-6sc-484723
50 mg
$180.00
(0)

Combined alpha and beta blocker, might indirectly affect GPCR pathways including Olr657.

Pindolol

13523-86-9sc-204847
sc-204847A
100 mg
1 g
$194.00
$760.00
(1)

Beta-adrenergic antagonist, could influence GPCR-mediated signaling pathways related to Olr657.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Non-selective beta-adrenergic agonist, could indirectly affect Olr657 through GPCR modulation.

Atropine

51-55-8sc-252392
5 g
$204.00
2
(1)

Muscarinic acetylcholine receptor antagonist, might influence GPCR signaling pathways including Olr657.

Salmeterol

89365-50-4sc-224277
sc-224277A
10 mg
50 mg
$186.00
$562.00
1
(1)

Long-acting beta-2 adrenergic agonist, potentially affecting GPCR pathways related to Olr657.

Alprenolol

13655-52-2sc-507469
50 mg
$130.00
(0)

Non-selective beta blocker, could indirectly influence GPCR signaling pathways including Olr657.